An open clinical trial of benazepril--a new ACE inhibitor in mild-moderate hypertension.
dc.contributor.author | Karnik, N D | en_US |
dc.contributor.author | Oza, Y K | en_US |
dc.contributor.author | Sane, S P | en_US |
dc.contributor.author | Kaushik, R | en_US |
dc.contributor.author | Bhatt, A D | en_US |
dc.contributor.author | Chawla, K P | en_US |
dc.contributor.author | Vaidya, A B | en_US |
dc.contributor.author | Yajnik, V H | en_US |
dc.contributor.author | Khokhani, R C | en_US |
dc.date.accessioned | 1998-03-29 | en_US |
dc.date.accessioned | 2009-05-30T22:31:46Z | |
dc.date.available | 1998-03-29 | en_US |
dc.date.available | 2009-05-30T22:31:46Z | |
dc.date.issued | 1998-03-29 | en_US |
dc.description.abstract | Benazepril hydrochloride, a new non-sulfhydryl ACE inhibitor (ACEI) was studied in a titrated dose of 10 mg-20 mg once a day for 6 weeks in 42 mild to moderate adult hypertensive patients with sitting diastolic blood pressure (SDBP) 95-114 mm Hg. The pre-drug SDBP(mean +/- SE) of 102.5 +/- 0.8 mm Hg showed a significant reduction to 87.5 +/- 0.93 mm Hg at the end of treatment. BP was controlled (SDBP < or = 90 mm Hg) in 34 (81%) patients and a drop of at least 10 mm Hg from the pre-treatment SDBP value was noted in 34 (81%) patients. Common adverse reaction was cough in 8(19%) patients. Clinically significant changes in laboratory evaluations were not seen in any patient. Study showed that benazepril in a dose range of 10 to 20 mg per day is an effective agent for treatment of mild to moderate hypertension. | en_US |
dc.description.affiliation | LTM Medical College and Hospital, Mumbai. | en_US |
dc.identifier.citation | Karnik ND, Oza YK, Sane SP, Kaushik R, Bhatt AD, Chawla KP, Vaidya AB, Yajnik VH, Khokhani RC. An open clinical trial of benazepril--a new ACE inhibitor in mild-moderate hypertension. Journal of the Association of Physicians of India. 1998 Mar; 46(3): 283-5 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/89608 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://www.japi.org | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Angiotensin-Converting Enzyme Inhibitors --therapeutic use | en_US |
dc.subject.mesh | Benzazepines --therapeutic use | en_US |
dc.subject.mesh | Blood Pressure --drug effects | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Hypertension --drug therapy | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Middle Aged | en_US |
dc.title | An open clinical trial of benazepril--a new ACE inhibitor in mild-moderate hypertension. | en_US |
dc.type | Clinical Trial | en_US |
dc.type | Journal Article | en_US |
dc.type | Multicenter Study | en_US |
Files
License bundle
1 - 1 of 1